On Thursday, Piper Sandler confirmed its constructive stance on ESSA Pharma (NASDAQ:) shares, sustaining an Chubby ranking and a $15.00…
Our selection of the week's biggest research news and features sent directly to your inbox. Enter your email address, confirm you're happy to receive our emails.
Please contact salesdepartment
for further information at:
Sales@88.broker
Sign in to your account
Username or Email Address
Password
Remember Me